Pembrolizumab’s Perioperative Power in Head and Neck Cancer
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...
Year: 2025: 2025
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue...
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...
Takeaways from day three of the AACR Annual Meeting 2025 included the inspiring Opening Ceremony, a panel on cancer...
The second day of the AACR Annual Meeting 2025 included a 5K run/walk, the conclusion of the Educational Program,...
The 11 early-career researchers selected as AACR NextGen Star 2025 explain how their area of cancer research could progress...
Special programs for high school and undergraduate students at the AACR Annual Meeting provide valuable opportunities for learning, networking,...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...